Amgen Inc. Earnings

Amgen Inc.’s revenue jumped 9.43% since last year same period to $8149Mn in the Q1 2025. On a quarterly growth basis, Amgen Inc. has generated -10.31% fall in its revenue since last 3-months.

Amgen Inc.’s net profit jumped 1630.97% since last year same period to $1730Mn in the Q1 2025. On a quarterly growth basis, Amgen Inc. has generated 175.92% jump in its net profits since last 3-months.

Amgen Inc.’s net profit margin jumped 1499.09% since last year same period to 21.23% in the Q1 2025. On a quarterly growth basis, Amgen Inc. has generated 207.64% jump in its net profit margins since last 3-months.

Amgen Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 26.38.

Amgen Inc.’s earning per share (EPS) estimates for the current quarter stand at 4.3 - a -15.35% fall from last quarter’s estimates.

Amgen Inc.’s earning per share (EPS) estimates for the current year stand at 4.3.

Amgen Inc.’s earning per share (EPS) jumped 23.74% since last year same period to 4.9 in the Q1 2025. This indicates that the Amgen Inc. has generated 23.74% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amgen Inc.’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amgen Inc.’s return on equity (ROE) stands at 1.06.

Amgen Inc. declared 2.38 dividend per share during the earnings announcement for Q1 2025.